Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 4
2005 2
2006 4
2007 5
2008 6
2009 9
2010 4
2011 8
2012 3
2013 4
2014 1
2015 1
2016 4
2017 3
2018 2
2019 6
2020 7
2021 7
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series.
Pellegrini M, Carnevali A, Fiore T, Cagini C, De Palma A, Fontana L, Lupardi E, Cassini F, Bacherini D, Giansanti F, Giannaccare G, Scorcia V, Vaccaro S, Ciarmatori N, D'Angelo S, Parmeggiani F, Mura M. Pellegrini M, et al. Among authors: parmeggiani f. Eye (Lond). 2023 Oct;37(14):3000-3003. doi: 10.1038/s41433-023-02459-2. Epub 2023 Feb 22. Eye (Lond). 2023. PMID: 36813998 Free article.
RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study.
Testa F, Murro V, Signorini S, Colombo L, Iarossi G, Parmeggiani F, Falsini B, Salvetti AP, Brunetti-Pierri R, Aprile G, Bertone C, Suppiej A, Romano F, Karali M, Donati S, Melillo P, Sodi A, Quaranta L, Rossetti L, Buzzonetti L, Chizzolini M, Rizzo S, Staurenghi G, Banfi S, Azzolini C, Simonelli F. Testa F, et al. Among authors: parmeggiani f. Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):13. doi: 10.1167/iovs.63.2.13. Invest Ophthalmol Vis Sci. 2022. PMID: 35129589 Free PMC article.
The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
Black GC, Sergouniotis P, Sodi A, Leroy BP, Van Cauwenbergh C, Liskova P, Grønskov K, Klett A, Kohl S, Taurina G, Sukys M, Haer-Wigman L, Nowomiejska K, Marques JP, Leroux D, Cremers FPM, De Baere E, Dollfus H; ERN-EYE study group. Black GC, et al. Orphanet J Rare Dis. 2021 Mar 20;16(1):142. doi: 10.1186/s13023-021-01756-x. Orphanet J Rare Dis. 2021. PMID: 33743793 Free PMC article.
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers.
dell'Omo R, Filippelli M, Virgili G, Bandello F, Querques G, Lanzetta P, Avitabile T, Viola F, Reibaldi M, Semeraro F, Quaranta L, Rizzo S, Midena E, Campagna G, Costagliola C; Eyecare in Italy during COVID-19 pandemic (EICO) study group. dell'Omo R, et al. Eur J Ophthalmol. 2022 Jan;32(1):695-703. doi: 10.1177/11206721211002442. Epub 2021 Mar 16. Eur J Ophthalmol. 2022. PMID: 33724078
82 results